Literature DB >> 6645788

Distribution of chlorpromazine and imipramine in adipose and other tissues of rats.

M H Bickel, B E Graber, M Moor.   

Abstract

Adipose tissue kinetics of chlorpromazine and imipramine, two drugs which are more lipophilic than thiopental, were studied in the rat. After single i.v. doses, the time-course of drug distribution was followed in adipose and various other tissues, until their concentrations in adipose tissues declined. Under these conditions the two drugs behaved almost identically. Among the tissues analyzed, the lowest concentrations were found in adipose tissue, with the exception of plasma. At its maximum concentration after about 30 minutes, total adipose tissue contained only 3% of the dose of administered drugs. Adipose/plasma and adipose/lung concentration ratios were 2-5 and 0.05, respectively. After maximum tolerated oral doses of imipramine for 3 weeks, similar steady state concentration ratios (plasma:adipose:brain:lung 1:3:12:96) were observed. In adipose tissue the imipramine/desmethylimipramine ratio was about 1, and the desmethylimipramine steady state levels did not increase with time. Literature data indicate that many basic lipophilic drugs are not stored in adipose tissue. This is now clearly shown for chlorpromazine and imipramine, even under extreme, subchronic conditions in the case of imipramine.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6645788     DOI: 10.1016/0024-3205(83)90742-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Pharmacokinetics and metabolism of thioridazine during co-administration of tricyclic antidepressants.

Authors:  W A Daniel; M Syrek; A Haduch; J Wójcikowski
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

2.  Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.

Authors:  Ryan S Funk; Jeffrey P Krise
Journal:  Mol Pharm       Date:  2012-04-06       Impact factor: 4.939

3.  Potentiation of the action of adenosine on cerebral cortical neurones by the tricyclic antidepressants.

Authors:  J W Phillis
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

Review 4.  Clinical pharmacokinetics of imipramine and desipramine.

Authors:  F R Sallee; B G Pollock
Journal:  Clin Pharmacokinet       Date:  1990-05       Impact factor: 6.447

5.  Effects of psychotropic agents on the physical properties of platelet membranes in vitro.

Authors:  G S Zubenko; B M Cohen
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics.

Authors:  Jee-Eun Oh; Yoon Mi Cho; Su-Nam Kwak; Jae-Hyun Kim; Kyung Won Lee; Hyosan Jung; Seong-Whan Jeong; Oh-Joo Kwon
Journal:  Exp Mol Med       Date:  2012-09-30       Impact factor: 8.718

7.  Repurposing chlorpromazine to treat COVID-19: The reCoVery study.

Authors:  M Plaze; D Attali; A-C Petit; M Blatzer; E Simon-Loriere; F Vinckier; A Cachia; F Chrétien; R Gaillard
Journal:  Encephale       Date:  2020-05-16       Impact factor: 1.291

8.  [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].

Authors:  M Plaze; D Attali; A-C Petit; M Blatzer; E Simon-Loriere; F Vinckier; A Cachia; F Chrétien; R Gaillard
Journal:  Encephale       Date:  2020-04-29       Impact factor: 1.291

9.  Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine.

Authors:  Marion Plaze; David Attali; Matthieu Prot; Anne-Cécile Petit; Michael Blatzer; Fabien Vinckier; Laurine Levillayer; Jeanne Chiaravalli; Florent Perin-Dureau; Arnaud Cachia; Gérard Friedlander; Fabrice Chrétien; Etienne Simon-Loriere; Raphaël Gaillard
Journal:  Int J Antimicrob Agents       Date:  2020-12-30       Impact factor: 5.283

10.  Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro.

Authors:  Jiayu Lu; Yajing Hou; Shuai Ge; Xiangjun Wang; Jue Wang; Tian Hu; Yuexin Lv; Huaizhen He; Cheng Wang
Journal:  Life Sci       Date:  2020-12-10       Impact factor: 6.780

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.